LivaNova to Announce First-Quarter 2024 Results
LivaNova PLC (Nasdaq: LIVN) will discuss its first-quarter 2024 results in a conference call on May 1, 2024. The live audiocast will be accessible on their website. Listeners can also join via telephone. A replay will be available on the website for 90 days post-call.
03/21/2024 - 09:00 AM
LONDON --(BUSINESS WIRE)--
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, will host a conference call to discuss its first-quarter 2024 results on Wednesday, May 1, 2024 at 1 p.m. London time (8 a.m. Eastern Time). The Company will release its first-quarter 2024 results prior to the call.
A live audiocast will be accessible at www.livanova.com/events . Listeners should log on approximately 10 minutes in advance to ensure proper setup to receive the audiocast. To listen to the conference call by telephone, dial +1 833 470 1428 (if dialing from within the U.S. ) or +1 929 526 1599 (if dialing from outside the U.S. ). The conference call access code is 556837. A replay will be available on the LivaNova website for 90 days following the call.
About LivaNova
LivaNova PLC is a global medical technology company built on nearly five decades of experience and a relentless commitment to provide hope for patients and their families through medical technologies, delivering life-changing improvements for both the Head and Heart. Headquartered in London , LivaNova employs approximately 2,900 employees and has a presence in more than 100 countries for the benefit of patients, healthcare professionals and healthcare systems worldwide. For more information, please visit www.livanova.com .
Safe Harbor Statement
This news release contains “forward-looking statements” concerning the Company’s goals, beliefs, expectations, strategies, objectives, plans, underlying assumptions and other statements that are not necessarily based on historical facts. These statements include, but are not limited to, statements regarding the next Company conference call. Actual events may differ materially from those indicated in our forward-looking statements as a result of various factors, including those factors set forth in Item 1A of the Company’s most recent Annual Report on Form 10-K, as supplemented by any risk factors contained in Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. LivaNova undertakes no obligation to update the information contained in this press release to reflect subsequently occurring events or circumstances.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240321773717/en/
LivaNova Investor Relations and Media Contacts
+1 281-895-2382
Briana Gotlin
Director, Investor Relations
InvestorRelations@livanova.com
Deanna Wilke
VP, Corporate Communications
Corporate.Communications@livanova.com
Source: LivaNova PLC
When will LivaNova PLC discuss its first-quarter 2024 results?
LivaNova PLC will discuss its first-quarter 2024 results on May 1, 2024.
Where can listeners access the live audiocast of the conference call?
Listeners can access the live audiocast of the conference call at www.livanova.com/events.
How can listeners join the conference call by telephone?
Listeners can join the conference call by telephone by dialing +1 833 470 1428 (if dialing from within the U.S.) or +1 929 526 1599 (if dialing from outside the U.S.).
How long will the replay of the conference call be available?
The replay of the conference call will be available on the LivaNova website for 90 days following the call.
LIVN Rankings
#1984 Ranked by Stock Gains
LIVN Stock Data
Industry
Surgical and Medical Instrument Manufacturing
Sector
Manufacturing
Tags
Health Technology, Medical Specialties, Manufacturing, Surgical and Medical Instrument Manufacturing
Country
United Kingdom
City
20 Eastbourne Terrace
About LIVN
livanova plc is a global medical technology company built on nearly five decades of experience and a relentless commitment to improve the lives of patients around the world. our advanced technologies and breakthrough treatments provide meaningful solutions for the benefit of patients, healthcare professionals and healthcare systems.at livanova, we understand the importance of bringing both clinical and economic value to our customers. we are a strong, market-leading medical technology and services company, offering a diverse product portfolio and global reach. livanova is listed on the nasdaq stock exchange under the ticker symbol “livn.” livanova has approximately 3,000 employees worldwide. we are headquartered in london (uk) and maintain a presence in more than 100 countries. livanova is a worldwide leader in advanced circulatory support, cardiopulmonary and neuromodulation, dedicated to creating meaningful products and therapies that transform lives each and every day.